My research interest lies mainly in discovering the novel molecular target to treat B cell leukemia and lymphoma. To do that, our lab leverages genetic engineered mouse model to study the role of gene of interests in 1) B cell development, 2) BCR-mediated immune response and 3) leukemogenesis.